IBSA is a global pharmaceutical company founded in Lugano in 1945. IBSA has 90 patent families in its portfolio, with more in development. In 2022 producing over 300 million soft gel capsules, 22 million hormone vials, and 67 million finished product packs across a broad product portfolio covering 10 therapeutic areas.

We have 20 subsidiaries across Europe, China, and the United States and are present in over 90 countries across 5 continents. Collectively we employ more than 2,000 people. Being one of the major players globally in reproductive medicine and one of the global leaders in hyaluronic acid-based products.